• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕中期利用母体血清标志物进行的18三体两步筛查

Second trimester two-step trisomy 18 screening using maternal serum markers.

作者信息

Muller Françoise, Sault Corinne, Lemay Catherine, Roussel-Mizon Nathalie, Forestier François, Frendo Jean-Louis

机构信息

Service de Biochimie, Hôpital Ambroise Paré, Boulogne, France.

出版信息

Prenat Diagn. 2002 Jul;22(7):605-8. doi: 10.1002/pd.345.

DOI:10.1002/pd.345
PMID:12124697
Abstract

Trisomy 21 maternal serum marker screening has led to screening for other anomalies, including trisomy 18. Trisomy 18 is generally prenatally diagnosed because of major morphological defects. However, in up to 30% of cases ultrasound signs are unclear, and in most cases diagnosis is performed late in pregnancy. Of the different maternal serum markers, PAPP-A is now considered as the best for trisomy 18 screening. However, pregnancy-associated plasma protein A (PAPP-A) is of value in first trimester screening for trisomy 21, but not in the second trimester. We therefore propose a two-step screening strategy. Based on 45 trisomy 18 cases, we confirm the values of alpha-fetoprotein (AFP) (median 0.61 MoM), free beta-human chorionic gonadotrophin (beta-hCG) (median 0.24 MoM) and of PAPP-A (median 0.08 MoM). In the first step, a 0.5 MoM cut-off for AFP or for free beta-hCG resulted in detection of 37/45 trisomy 18 cases (82%) with a 10% false-positive rate. The second step consisted of the measurement of PAPP-A for all these false-positive cases. Using a PAPP-A cut-off of 0.5 MoM, all the 37 trisomy 18 cases were detected, but now with a 0.1-0.2% false-positive rate. Amniocentesis was only offered to these few patients. This two-step second trimester screening will be of value for patients who have not been included in first trimester screening based on nuchal translucency (NT) measurement combined with the first trimester markers, PAPP-A and free beta-hCG.

摘要

21三体综合征的母体血清标志物筛查已促使对其他异常情况进行筛查,包括18三体综合征。18三体综合征通常因严重的形态学缺陷而在产前被诊断出来。然而,在高达30%的病例中,超声征象不明确,且在大多数情况下,诊断在妊娠晚期进行。在不同的母体血清标志物中,妊娠相关血浆蛋白A(PAPP-A)现在被认为是18三体综合征筛查的最佳标志物。然而,妊娠相关血浆蛋白A(PAPP-A)在孕早期筛查21三体综合征时有价值,但在孕中期则不然。因此,我们提出了一种两步筛查策略。基于45例18三体综合征病例,我们确定了甲胎蛋白(AFP)(中位数0.61 MoM)、游离β-人绒毛膜促性腺激素(β-hCG)(中位数0.24 MoM)和PAPP-A(中位数0.08 MoM)的值。第一步,AFP或游离β-hCG的截断值为0.5 MoM时,可检测出45例18三体综合征病例中的37例(82%),假阳性率为10%。第二步是对所有这些假阳性病例测量PAPP-A。使用PAPP-A截断值0.5 MoM时,所有37例18三体综合征病例均被检测出,但此时假阳性率为0.1 - 0.2%。仅对这少数患者进行羊膜穿刺术。对于那些未纳入基于颈部透明带(NT)测量结合孕早期标志物PAPP-A和游离β-hCG的孕早期筛查的患者,这种孕中期两步筛查将具有价值。

相似文献

1
Second trimester two-step trisomy 18 screening using maternal serum markers.孕中期利用母体血清标志物进行的18三体两步筛查
Prenat Diagn. 2002 Jul;22(7):605-8. doi: 10.1002/pd.345.
2
Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.18三体综合征病例中孕中期妊娠相关血浆蛋白A水平
Prenat Diagn. 1999 Dec;19(12):1127-34.
3
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.孕11⁺⁰至13⁺⁶周时,通过胎儿三尖瓣反流、颈部透明带以及母体血清游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白-A筛查21三体综合征。
Ultrasound Obstet Gynecol. 2006 Feb;27(2):151-5. doi: 10.1002/uog.2699.
4
Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.通过孕妇年龄、胎儿颈部透明带、游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白-A筛查18三体综合征。
Ultrasound Obstet Gynecol. 2008 Sep;32(4):488-92. doi: 10.1002/uog.6123.
5
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.孕中期13三体妊娠中妊娠相关血浆蛋白A和游离β-人绒毛膜促性腺激素的水平
Prenat Diagn. 2005 May;25(5):358-61. doi: 10.1002/pd.1151.
6
Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.孕早期唐氏综合征和18三体综合征筛查项目中的孕妇体重及种族校正
Prenat Diagn. 2005 Aug;25(8):635-40. doi: 10.1002/pd.1188.
7
Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.沙特孕妇孕10至13(+6)周时母体血清游离β-绒毛膜促性腺激素、妊娠相关血浆蛋白-A与胎儿颈部半透明层厚度与协变量的关系
Prenat Diagn. 2007 Apr;27(4):303-11. doi: 10.1002/pd.1661.
8
Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.75821例妊娠早期唐氏综合征21三体筛查的多中心研究:个体风险导向型两阶段早期妊娠筛查的结果及潜在影响评估
Ultrasound Obstet Gynecol. 2005 Mar;25(3):221-6. doi: 10.1002/uog.1860.
9
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.通过游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白A进行孕早期21三体综合征筛查:孕妇及妊娠特征的影响
Ultrasound Obstet Gynecol. 2008 May;31(5):493-502. doi: 10.1002/uog.5332.
10
The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.在孕早期使用母体血清生化指标和胎儿颈部透明带厚度筛查染色体异常时校正吸烟状态的影响。
Prenat Diagn. 2004 Mar;24(3):169-73. doi: 10.1002/pd.819.

引用本文的文献

1
Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.血清甲胎蛋白-IgM免疫复合物对原发性肝细胞癌诊断的临床评估
J Clin Lab Anal. 2009;23(4):213-8. doi: 10.1002/jcla.20321.